Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Dow
Johnson and Johnson
AstraZeneca
Covington
Colorcon
Mallinckrodt
Cerilliant
Chubb

Generated: September 20, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Omnaris

« Back to Dashboard

Bulk Pharmaceutical API Sources for Omnaris

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ➤ Try a Free Trial 6918155 ➤ Try a Free Trial
Hangzhou APIChem Technology ➤ Try a Free Trial AC-1330 ➤ Try a Free Trial
MolPort ➤ Try a Free Trial MolPort-005-940-705 ➤ Try a Free Trial
ChemMol ➤ Try a Free Trial 2100025 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Accenture
Chinese Patent Office
Healthtrust
US Army
Julphar
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.